[Chemotherapy and immunosuppression in patients with hepatitis B or C].
Sitruk
V
V
Service d'Hépato-Gastroentérologie, Hôpital Jean-Verdier, Bondy Cedex, France.
Fain
O
O
Gordien
E
E
Ganne-Carrié
N
N
Deny
P
P
Beaugrand
M
M
Trinchet
J C
JC
D000970:Antineoplastic Agents / Q000009:adverse effects*; D000075202:Contraindications; D016174:Hepacivirus / Q000254:growth & development; D006509:Hepatitis B / Q000188:drug therapy / Q000517:prevention & control; D006515:Hepatitis B virus / Q000254:growth & development; D006526:Hepatitis C / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D014775:Virus Activation
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents